Terodiline Hydrochloride

CHEMBL539770 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
317.9 g/mol
LogP
Phase
4

Terodiline hydrochloride is the hydrochloride salt form of terodiline, a withdrawn anticholinergic and calcium channel-blocking agent previously used for urinary incontinence. See terodiline for complete pharmacological details. The drug was withdrawn due to QT prolongation and cardiac arrhythmia risks.

Moleküler Ağırlık

317,9000 g/mol

TPSA

12,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C.Cl

InChI

InChI=1S/C20H27N.ClH/c1-16(21-20(2,3)4)15-19(17-11-7-5-8-12-17)18-13-9-6-10-14-18;/h5-14,16,19,21H,15H2,1-4H3;1H

Molecular Formula

C20H28ClN

HBD / HBA

2 / 1

Döndürülebilir Bağlar

6

Ağır Atomlar

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Terodiline hydrochloride is the hydrochloride salt form of terodiline, a withdrawn anticholinergic and calcium channel-blocking agent previously used for urinary incontinence. See terodiline for complete pharmacological details. The drug was withdrawn due to QT prolongation and cardiac arrhythmia risks.

Yes, Terodiline Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL539770. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23479. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.